Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cells

Jiang,Hong; Zhang,Xuemei; Luo,Jinhong; Dong,Chunyan; Xue,Junli; Wei,Wei; Chen,Jingde; Zhou,Jun; Gao,Yong; Yang,Changqing

doi:10.3892/mmr.2012.943

Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cells

Authors:
- Hong Jiang
- Xuemei Zhang
- Jinhong Luo
- Chunyan Dong
- Junli Xue
- Wei Wei
- Jingde Chen
- Jun Zhou
- Yong Gao
- Changqing Yang
View Affiliations

Affiliations: Department of Oncology, Shanghai East Hospital of Tongji University, Shanghai, P.R. China, Department of Gastroenterology, Tongji Hospital of Tongji University, Shanghai, P.R. China
Published online on: June 11, 2012 https://doi.org/10.3892/mmr.2012.943
Pages: 575-580

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

RNA-binding proteins (RBPs) play essential roles in RNA metabolism, regulating RNA splicing, transport, surveillance, decay and translation. The aberrant expression of RBPs leads to gene expression alteration and frequently causes various diseases, such as cancer. In this study, we are the first to provide evidence that hMex-3A, a RBP that belongs to the human Mex-3 family with two K-homology RNA-binding domains, is involved in the regulation of tumorigenesis. We show that the silencing of hMex-3A by small interference RNA effectively inhibits cell proliferation in SNU-16 and AGS gastric cancer cells. Flow cytometry analysis confirmed this effect on SNU-16 cell growth and indicated that hMex-3A may function in the G1/M phase. Notably, hMex-3A knockdown also reduced the colony formation ability of SNU-16 and AGS cells in soft agar, implying that hMex-3A is required for cell transformation. Furthermore, the hMex-3A knockdown markedly affected the migratory ability of BCG-823 cells by transwell chamber and wound healing assays. Clinical relevance analysis using 22 paired gastric cancer specimens by quantitative real-time PCR showed that hMex-3A was significantly upregulated (63.6%) in cancer tissues compared with matched adjacent non-cancerous tissues. Taken together, these results suggest that hMex-3A functions as an oncogene candidate in the development and metastasis of gastric cancer; thus it may serve as a potential target for the therapy of tumors.

View Figures

View References

1	Kim MY, Hur J and Jeong S: Emerging roles of RNA and RNA-binding protein network in cancer cells. BMB Rep. 42:125–130. 2009. View Article : Google Scholar : PubMed/NCBI
2	Lunde BM, Moore C and Varani G: RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol. 8:479–490. 2007. View Article : Google Scholar : PubMed/NCBI
3	Lukong KE, Chang KW, Khandjian EW and Richard S: RNA-binding proteins in human genetic disease. Trends Genet. 24:416–425. 2008. View Article : Google Scholar : PubMed/NCBI
4	Bielli P, Busa R, Paronetto MP and Sette C: The RNA-binding protein Sam68 is a multifunctional player in human cancer. Endocr Relat Cancer. 18:R91–R102. 2011. View Article : Google Scholar : PubMed/NCBI
5	Shultz JC, Goehe RW, Murudkar CS, et al: SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells. Mol Cancer Res. 9:889–900. 2011. View Article : Google Scholar
6	Denkert C, Koch I, von Keyserlingk N, et al: Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod Pathol. 19:1261–1269. 2006. View Article : Google Scholar : PubMed/NCBI
7	Gherzi R, Trabucchi M, Ponassi M, et al: The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol. 5:e52006. View Article : Google Scholar : PubMed/NCBI
8	Lee HK and Jeong S: Beta-catenin stabilizes cyclooxygenase-2 mRNA by interacting with AU-rich elements of 3′-UTR. Nucleic Acids Res. 34:5705–5714. 2006.PubMed/NCBI
9	Buchet-Poyau K, Courchet J, Le Hir H, et al: Identification and characterization of human Mex-3 proteins, a novel family of evolutionarily conserved RNA-binding proteins differentially localized to processing bodies. Nucleic Acids Res. 35:1289–1300. 2007. View Article : Google Scholar : PubMed/NCBI
10	Fornerod M, Ohno M, Yoshida M and Mattaj IW: CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 90:1051–1060. 1997. View Article : Google Scholar : PubMed/NCBI
11	Parisi C, Giorgi C, Batassa EM, et al: Ago1 and Ago2 differentially affect cell proliferation, motility and apoptosis when overexpressed in SH-SY5Y neuroblastoma cells. FEBS Lett. 585:2965–2971. 2011. View Article : Google Scholar : PubMed/NCBI
12	Alberts SR, Cervantes A and van de Velde CJ: Gastric cancer: epidemiology, pathology and treatment. Ann Oncol. 14(Suppl 2): ii31–36. 2003. View Article : Google Scholar : PubMed/NCBI
13	Kim YB, Lee SY, Ye SK and Lee JW: Epigenetic regulation of integrin-linked kinase expression depending on adhesion of gastric carcinoma cells. Am J Physiol Cell Physiol. 292:C857–866. 2007. View Article : Google Scholar : PubMed/NCBI
14	Xu X, Li W, Fan X, et al: Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer. Oncogene. 26:7371–7379. 2007. View Article : Google Scholar : PubMed/NCBI
15	Joazeiro CA and Weissman AM: RING finger proteins: mediators of ubiquitin ligase activity. Cell. 102:549–552. 2000. View Article : Google Scholar : PubMed/NCBI
16	Fang S, Lorick KL, Jensen JP and Weissman AM: RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer. Semin Cancer Biol. 13:5–14. 2003. View Article : Google Scholar : PubMed/NCBI
17	Draper BW, Mello CC, Bowerman B, Hardin J and Priess JR: MEX-3 is a KH domain protein that regulates blastomere identity in early C. elegans embryos. Cell. 87:205–216. 1996. View Article : Google Scholar : PubMed/NCBI
18	Hunter CP and Kenyon C: Spatial and temporal controls target pal-1 blastomere-specification activity to a single blastomere lineage in C. elegans embryos. Cell. 87:217–226. 1996. View Article : Google Scholar : PubMed/NCBI
19	Gubin MM, Calaluce R, Davis JW, et al: Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis. Cell Cycle. 9:3337–3346
20	Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature. 435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
21	Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006. View Article : Google Scholar : PubMed/NCBI
22	Janowski BA, Huffman KE, Schwartz JC, et al: Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat Struct Mol Biol. 13:787–792. 2006. View Article : Google Scholar : PubMed/NCBI
23	Adams BD, Claffey KP and White BA: Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology. 150:14–23. 2009. View Article : Google Scholar